Advertisement

Randomized controlled trial of hemostatic powder versus endoscopic clipping for non-variceal upper gastrointestinal bleeding

  • Felipe Iankelevich BaracatEmail author
  • Diogo Turiani Hourneaux de Moura
  • Vítor Ottoboni Brunaldi
  • Caio Vinicius Tranquillini
  • Renato Baracat
  • Paulo Sakai
  • Eduardo Guimarães Hourneaux de Moura
Article
  • 84 Downloads

Abstract

Background and aims

Despite advances in pharmacological and endoscopic management of non-variceal upper gastrointestinal bleeding (NVUGIB), mortality is still relevant. TC-325 (Hemospray-Cook Medical) is a mineral powder with adsorptive properties, designed for endoscopic hemostasis. There are still no comparative trials studying this new hemostatic modality. The objective of this research was to compare the use of TC-325 (associated with epinephrine injection) with the combined technique of endoscopic clipping and epinephrine injection for the treatment of patients with NVUGIB.

Methods

We conducted a pilot randomized controlled trial with patients that presented NVUGIB with an actively bleeding lesion at the endoscopic evaluation. Patients were randomized either to the Hemospray or Hemoclip group. The randomization list was generated by a computer program and remained unknown throughout the entire trial. All patients underwent second-look endoscopy.

Results

Thirty-nine patients were enrolled. Peptic ulcer was the most frequent etiology. Primary hemostasis was achieved in all Hemospray cases and in 90% of Hemoclip group (p = 0.487). Five patients in Hemospray group underwent an additional hemostatic procedure during second-look endoscopy, while no patient in the Hemoclip group needed it (p = 0.04). Rebleeding, emergency surgery and mortality rates were similar in both groups. No toxicity, allergy events, or gastrointestinal obstruction signs were observed in Hemospray group.

Conclusions

TC-325 presents similar hemostatic results when compared with conventional dual therapy for patients with NVUGIB. Hemospray’s excellent primary hemostasis rate certifies it as a valuable tool in arduous situations of severe bleeding or difficult location site.

Keywords

Gastrointestinal bleeding Endoscopic hemostasis Hemospray Randomized controlled trial 

Notes

Compliance with ethical standards

Disclosures

Felipe Iankelevich Baracat, Diogo Turiani Hourneaux de Moura, Vítor Ottoboni Brunaldi, Caio Vinicius Tranquillini, Renato Baracat, Paulo Sakai, and Eduardo Guimarães Hourneaux de Moura declare that they have no conflict of interest or financial ties to disclose.

References

  1. 1.
    Rockall TA, Logan RF, Devlin HB, Northfield TC (1995) Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 311:222–226CrossRefGoogle Scholar
  2. 2.
    Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P (2010) International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 152:101–113CrossRefGoogle Scholar
  3. 3.
    Baracat F, Moura E, Bernardo W, Pu LZ, Mendonça E, Moura D, Baracat R, Ide E (2016) Endoscopic hemostasis for peptic ulcer bleeding: systematic review and meta-analyses of randomized controlled trials. Surg Endosc 30(6):2155–2168CrossRefGoogle Scholar
  4. 4.
    Ribeiro IB, Rezende DT, Madruga Neto AC, Ide E, Furuya CK, De Moura DTH, De Moura EGH (2018) Endoscopic dual therapy for giant peptic ulcer hemorrhage. Endoscopy.  https://doi.org/10.1055/a-0665-4142 Google Scholar
  5. 5.
    Barkun AN, Martel M, Toubouti Y, Rahme E, Bardou M (2009) Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc 69:786–799CrossRefGoogle Scholar
  6. 6.
    Sreedharan A, Martin J, Leontiadis GI, Dorward S, Howden CW, Forman D, Moayyedi P (2010) Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev 7:CD005415Google Scholar
  7. 7.
    Laine L, Yang H, Chang SC, Datto C (2012) Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009. Am J Gastroenterol 107(8):1190–1195CrossRefGoogle Scholar
  8. 8.
    Imperiale TF, Dominitz JA, Provenzale DT, Boes LP, Rose CM, Bowers JC, Musick BS, Azzouz F, Perkins SM (2007) Predicting poor outcome from acute upper gastrointestinal hemorrhage. Arch Intern Med 167(12):1291–1296CrossRefGoogle Scholar
  9. 9.
    Al Dhahab H, McNabb-Baltar J, Al-Taweel T, Barkun A (2013) State-of-the-art management of acute bleeding peptic ulcer disease. Saudi J Gastroenterol 19(5):195–204CrossRefGoogle Scholar
  10. 10.
    Smith LA, Stanley AJ, Bergman JJ, Kiesslich R, Hoffman A, Tjwa ET, Kuipers EJ, von Holstein CS, Oberg S, Brullet E, Schmidt PN, Iqbal T, Mangiavillano B, Masci E, Prat F, Morris AJ (2014) Hemospray application in nonvariceal upper gastrointestinal bleeding: results of the Survey to Evaluate the Application of Hemospray in the Luminal Tract. J Clin Gastroenterol 48(10):e89–e92Google Scholar
  11. 11.
    Holster IL, van Beusekom HM, Kuipers EJ, Leebeek FW, de Maat MP, Tjwa ET (2015) Effects of a hemostatic powder hemospray on coagulation and clot formation. Endoscopy 47(7):638–645CrossRefGoogle Scholar
  12. 12.
    Sakai CM, Duarte RB, Baracat FI, Baracat R, Moura EGHM (2017) Endoscopic treatment of upper-GI ulcer bleeding with hemostatic powder spray. VideoGIE 2(1):12–13CrossRefGoogle Scholar
  13. 13.
    Baracat FI, Tranquillini CV, Brunaldi VO, Baracat R, Moura EGHM (2017) Hemostatic powder: a new ally in the management of postsphincterotomy bleeding. VideoGIE 2(11):303–304CrossRefGoogle Scholar
  14. 14.
    Pittayanon R, Rerknimitr R, Barkun A (2018) Prognostic factors affecting outcomes in patients with malignant GI bleeding treated with a novel endoscopically delivered hemostatic powder. Gastrointest Endosc 87(4):994–1002CrossRefGoogle Scholar
  15. 15.
    Holster IL, Kuipers EJ, Tjwa ET (2013) Hemospray in the treatment of upper gastrointestinal haemorrhage in patients on antithrombotic therapy. Endoscopy 45:63–66CrossRefGoogle Scholar
  16. 16.
    Schulz KF, Altman DG, Moher D, CONSORT Group (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332CrossRefGoogle Scholar
  17. 17.
    Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381CrossRefGoogle Scholar
  18. 18.
    SNOMED CT (2018) Systematised Nomenclature fo Medicine Clinical Terms. http://www.nlm.nih.gov/research/ulms/Snomed/snomed_main.html. Accessed 23 Sept 2018
  19. 19.
    Kwek BEA, Ang TL, Ong PLJ, Tan YLJ, Ang SWD, Law NM, Thurairajah PH, Fock KM (2017) TC-325 versus the conventional combined technique for endoscopic treatment of peptic ulcers with high-risk bleeding stigmata: a randomized pilot study. J Dig Dis 18(6):323–329CrossRefGoogle Scholar
  20. 20.
    Kim YJ, Park JC, Kim EH, Shin SK, Lee SK, Lee YC (2018) Hemostatic powder application for control of acute upper gastrointestinal bleeding in patients with gastric malignancy. Endosc Int Open 6(6):E700–E705CrossRefGoogle Scholar
  21. 21.
    Cahyadi O, Bauder M, Meier B, Caca K, Schmidt A (2017) Effectiveness of TC-325 (Hemospray) for treatment of diffuse or refractory upper gastrointestinal bleeding - a single center experience. Endosc Int Open 5(11):E1159–E1164CrossRefGoogle Scholar
  22. 22.
    Haddara S, Jacques J, Lecleire S, Branche J, Leblanc S, Le Baleur Y, Privat J, Heyries L, Bichard P, Granval P, Chaput U, Koch S, Levy J, Godart B, Charachon A, Bourgaux JF, Metivier-Cesbron E, Chabrun E, Quentin V, Perrot B, Vanbiervliet G, Coron E (2016) A novel hemostatic powder for upper gastrointestinal bleeding: a multicenter study (the “GRAPHE” registry). Endoscopy 48(12):1084–1095CrossRefGoogle Scholar
  23. 23.
    Yau AHL, Ou G, Galorport C, Amar J, Bressler B, Donnellan F, Ko HH, Lam E, Enns RA (2014) Safety and efficacy of Hemospray® in upper gastrointestinal bleeding. Can J Gastroenterol Amp Hepatol 28:72–76CrossRefGoogle Scholar
  24. 24.
    Thomson M, Urs A, Narula P, Rao P, Belsha D (2018) The Use and Safety of a Novel Haemostatic Spray in the Endoscopic Management of Acute Nonvariceal Upper Gastrointestinal Bleeding in Children. J Pediatr Gastroenterol Nutr 67(3):e47–e50CrossRefGoogle Scholar
  25. 25.
    Chen Y-I, Barkun A, Nolan S (2015) Hemostatic powder TC-325 in the man- agement of upper and lower gastrointestinal bleeding: a two-year ex- perience at a single institution. Endoscopy 47:167–171Google Scholar
  26. 26.
    Kumar NL, Claggett BL, Cohen AJ, Nayor J, Saltzman JR (2017) Association between an increase in blood urea nitrogen at 24 hours and worse outcomes in acute nonvariceal upper GI bleeding. Gastrointest Endosc 86(6):1022–1027CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Felipe Iankelevich Baracat
    • 1
    Email author
  • Diogo Turiani Hourneaux de Moura
    • 1
  • Vítor Ottoboni Brunaldi
    • 1
  • Caio Vinicius Tranquillini
    • 1
  • Renato Baracat
    • 1
  • Paulo Sakai
    • 1
  • Eduardo Guimarães Hourneaux de Moura
    • 1
  1. 1.Gastrointestinal Endoscopy Unit, Gastroenterology DepartmentUniversity of Sao Paulo Medical SchoolSão PauloBrazil

Personalised recommendations